Literature DB >> 23129218

Modeling and characterization of inflammatory breast cancer emboli grown in vitro.

Heather L Lehman1, Erica J Dashner, Michelle Lucey, Peter Vermeulen, Luc Dirix, Steven Van Laere, Kenneth L van Golen.   

Abstract

Inflammatory breast cancer (IBC) is the deadliest form of breast cancer, presenting as intralymphatic emboli. Emboli within the dermal lymphatic vessels are thought to contribute to rapid metastasis. The lack of appropriate in vitro models has made it difficult to accurately study how IBC emboli metastasize. To date, attempts at creating IBC tumor emboli in vitro have used 3D culture on a solid layer of Matrigel(TM) , which does not resemble the physical properties of the lymphatic system. Dermal lymphatic fluid produces oscillatory fluid shear forces and is 1.5-1.7-fold more viscous than water with a pH range of 7.5-7.7. We have established a method for forming tumor emboli by culturing the IBC cell lines in suspension with either polyethylene glycol- or hyaluronic acid-containing medium and oscillatory fluid shear forces. Non-IBC cells do not form emboli under identical conditions. In vitro IBC emboli were analyzed for expression of markers associated with patient emboli and their ability to undergo invasion. In a direct comparison, the in vitro IBC emboli closely resemble IBC patient emboli with respect to size, composition and E-cadherin expression. Further, cells from the emboli are able to invade in clusters via RhoC GTPase-dependent amoeboid movement. Invasion by clusters of IBC cells is disrupted by exposure to TGFβ. This study provides a biologically relevant in vitro model to accurately grow and study inflammatory breast cancer biology and metastasis.
Copyright © 2012 UICC.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 23129218     DOI: 10.1002/ijc.27928

Source DB:  PubMed          Journal:  Int J Cancer        ISSN: 0020-7136            Impact factor:   7.396


  20 in total

1.  Toward understanding cancer stem cell heterogeneity in the tumor microenvironment.

Authors:  Federico Bocci; Larisa Gearhart-Serna; Marcelo Boareto; Mariana Ribeiro; Eshel Ben-Jacob; Gayathri R Devi; Herbert Levine; José Nelson Onuchic; Mohit Kumar Jolly
Journal:  Proc Natl Acad Sci U S A       Date:  2018-12-26       Impact factor: 11.205

Review 2.  Inflammatory Breast Cancer: a Separate Entity.

Authors:  Jennifer M Rosenbluth; Beth A Overmoyer
Journal:  Curr Oncol Rep       Date:  2019-08-15       Impact factor: 5.075

3.  Dermoscopy of inflammatory breast cancer.

Authors:  María Gabriela Vallone; Virginia Mariana González; José Gabriel Casas; Margarita Larralde
Journal:  An Bras Dermatol       Date:  2018-03       Impact factor: 1.896

4.  RhoA and RhoC differentially modulate estrogen receptor α recruitment, transcriptional activities, and expression in breast cancer cells (MCF-7).

Authors:  Emilie Malissein; Elise Meunier; Isabelle Lajoie-Mazenc; Claire Médale-Giamarchi; Florence Dalenc; Sophie F Doisneau-Sixou
Journal:  J Cancer Res Clin Oncol       Date:  2013-10-06       Impact factor: 4.553

Review 5.  Three-dimensional culture systems in cancer research: Focus on tumor spheroid model.

Authors:  Sritama Nath; Gayathri R Devi
Journal:  Pharmacol Ther       Date:  2016-04-08       Impact factor: 12.310

6.  Pharmacological targeting of GLI1 inhibits proliferation, tumor emboli formation and in vivo tumor growth of inflammatory breast cancer cells.

Authors:  Helen O Oladapo; Michael Tarpley; Scott J Sauer; Kezia A Addo; Shalonda M Ingram; Dillon Strepay; Ben K Ehe; Lhoucine Chdid; Michael Trinkler; Jose R Roques; David B Darr; Jodie M Fleming; Gayathri R Devi; Kevin P Williams
Journal:  Cancer Lett       Date:  2017-09-28       Impact factor: 8.679

7.  Understanding the effect of mechanical forces on ovarian cancer progression.

Authors:  A Martinez; M Buckley; C B Scalise; A A Katre; J J Dholakia; D Crossman; M J Birrer; J L Berry; R C Arend
Journal:  Gynecol Oncol       Date:  2021-04-20       Impact factor: 5.304

Review 8.  Inflammatory breast cancer: New factors contribute to disease etiology: A review.

Authors:  Mona M Mohamed; Diaa Al-Raawi; Salwa F Sabet; Mohamed El-Shinawi
Journal:  J Adv Res       Date:  2013-06-14       Impact factor: 10.479

9.  In vitro vascularized tumor platform for modeling tumor-vasculature interactions of inflammatory breast cancer.

Authors:  Manasa Gadde; Caleb Phillips; Neda Ghousifam; Anna G Sorace; Enoch Wong; Savitri Krishnamurthy; Anum Syed; Omar Rahal; Thomas E Yankeelov; Wendy A Woodward; Marissa N Rylander
Journal:  Biotechnol Bioeng       Date:  2020-07-21       Impact factor: 4.530

10.  The Third International Inflammatory Breast Cancer Conference.

Authors:  Kenneth L van Golen; Massimo Cristofanilli
Journal:  Breast Cancer Res       Date:  2013-11-05       Impact factor: 6.466

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.